Oral vinorelbin in combination with cisplatin or carboplatin in
adjutant chemotherapy of non-snall lung cancer: A prospective
study of feasibility, tolerabity an 3-year surfoval

a 2011

Oral vinorelbin in combination with cisplatin or carboplatin in adjutant chemotherapy of non-snall lung cancer: A prospective study of feasibility, tolerabity an 3-year surfoval

KOLEK, Vítězslav; Ivona GRYGÁRKOVÁ; Jiří CHALUPA; Leona KOUBKOVÁ; Jiřina ŠVECOVÁ et al.

Základní údaje

Originální název

Oral vinorelbin in combination with cisplatin or carboplatin in adjutant chemotherapy of non-snall lung cancer: A prospective study of feasibility, tolerabity an 3-year surfoval

Autoři

KOLEK, Vítězslav; Ivona GRYGÁRKOVÁ; Jiří CHALUPA; Leona KOUBKOVÁ; Jiřina ŠVECOVÁ; Jana SKŘIČKOVÁ; Lenka OSTŘÍŽKOVÁ a Dimka SIXTOVÁ

Vydání

Journal of Thoracic Oncology, Volume 6, Supplement 2, Proceedings of the14th World Conference on Lung Cancer, 2011

Další údaje

Jazyk

angličtina

Typ výsledku

Konferenční abstrakt

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 3.661

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/11:00052780

Organizační jednotka

Lékařská fakulta

ISSN

Klíčová slova anglicky

oral vinorelbine; Adjuvant; chemotherapy; short time survival; NSCLC

Změněno: 15. 9. 2011 13:57, Mgr. Michal Petr

Anotace

V originále

Adjuvant cisplatinum-based chemotherapy is recommended for routine use in patients with stages IIA, IIB, and IIIA of non smallcell lung cancer (NSCLC) after radical resection. Results in stage IB were not conclusive. Vinorelbine is a preferable associated drug in this indication and a randomized study proved the comparable effectiveness and tolerability of vinorelbine given both orally or intravenously (i.v.) in advanced NSCLC, meanwhile oral vinorelbine gives better comfort to patients.

Citovat

KOLEK, Vítězslav; Ivona GRYGÁRKOVÁ; Jiří CHALUPA; Leona KOUBKOVÁ; Jiřina ŠVECOVÁ; Jana SKŘIČKOVÁ; Lenka OSTŘÍŽKOVÁ a Dimka SIXTOVÁ. Oral vinorelbin in combination with cisplatin or carboplatin in adjutant chemotherapy of non-snall lung cancer: A prospective study of feasibility, tolerabity an 3-year surfoval. In Journal of Thoracic Oncology, Volume 6, Supplement 2, Proceedings of the14th World Conference on Lung Cancer. 2011. ISSN 1556-0864.

@proceedings{946761,
   author = {Kolek, Vítězslav and Grygárková, Ivona and Chalupa, Jiří and Koubková, Leona and Švecová, Jiřina and Skřičková, Jana and Ostřížková, Lenka and Sixtová, Dimka},
   booktitle = {Journal of Thoracic Oncology, Volume 6, Supplement 2, Proceedings of the14th World Conference on Lung Cancer},
   keywords = {oral vinorelbine; Adjuvant; chemotherapy; short time survival; NSCLC},
   language = {eng},
   title = {Oral vinorelbin in combination with cisplatin or carboplatin in adjutant chemotherapy of non-snall lung cancer: A prospective study of feasibility, tolerabity an 3-year surfoval},
   year = {2011}
}

TY  - CONF
ID  - 946761
AU  - Kolek, Vítězslav - Grygárková, Ivona - Chalupa, Jiří - Koubková, Leona - Švecová, Jiřina - Skřičková, Jana - Ostřížková, Lenka - Sixtová, Dimka
PY  - 2011
TI  - Oral vinorelbin in combination with cisplatin or carboplatin in adjutant chemotherapy of non-snall lung cancer: A prospective study of feasibility, tolerabity an 3-year surfoval
KW  - oral vinorelbine
KW  - Adjuvant
KW  - chemotherapy
KW  - short time survival
KW  - NSCLC
N2  - Adjuvant cisplatinum-based chemotherapy is recommended for routine use in patients with stages IIA, IIB, and IIIA of non smallcell lung cancer (NSCLC) after radical resection. Results in stage IB were not conclusive. Vinorelbine is a preferable associated drug in this indication and a randomized study proved the comparable effectiveness and tolerability of vinorelbine given both orally or intravenously (i.v.) in advanced NSCLC, meanwhile oral vinorelbine gives better comfort to patients.
ER  -

KOLEK, Vítězslav; Ivona GRYGÁRKOVÁ; Jiří CHALUPA; Leona KOUBKOVÁ; Jiřina ŠVECOVÁ; Jana SKŘIČKOVÁ; Lenka OSTŘÍŽKOVÁ a Dimka SIXTOVÁ. Oral vinorelbin in combination with cisplatin or carboplatin in adjutant chemotherapy of non-snall lung cancer: A prospective study of feasibility, tolerabity an 3-year surfoval. In \textit{Journal of Thoracic Oncology, Volume 6, Supplement 2, Proceedings of the14th World Conference on Lung Cancer}. 2011. ISSN~1556-0864.

Přehled o publikaci